News

Xcel Brands, Inc. (NASDAQ: XELB) ("Xcel” or the "Company”), today announced that on April 29, 2025, it received a delinquency ...
NEW YORK and SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- Nasdaq Private Market (NPM), a leading provider of secondary ...
The Company has filed a notice of appeal and requested a hearing before a Nasdaq Listing Qualifications Panel to review the ...
Terns Pharmaceuticals, Inc. ("Terns” or the "Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing ...
Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on ...
Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum's Board of Directors granted inducement awards consisting of non-qualified stock options to ...